LABOMEDIC: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LABOMEDIC
Largest movements
- Tangible fixed assets +€20,839
up €20,839 (+4.9%), from €429,225 to €450,064
of which Land and buildings: +€21,459
- Cash +€6,401
up €6,401 (+2021.9%), from €317 to €6,718
mainly Other debts (+€37,747) and Depreciation (+€24,465)
- Current investments +€5,456
up €5,456 (+6.8%), from €80,000 to €85,456
- Other debts +€37,747
up €37,747 (+117.3%), from €32,180 to €69,927
- Current portion of long-term debt -€12,367
no longer reported in 2025 (was €12,367)
- Financial income +€5,456
new in 2025: €5,456
- Taxes +€2,479
up €2,479 (+1251.4%), from €198 to €2,677
- Gross operating margin +€451
up €451 (+1.6%), from €27,816 to €28,267
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €509,541 | €542,238 | +€32,696 | +6.4% |
| Fixed assets | 21/28 | €429,225 | €450,064 | +€20,839 | +4.9% |
| Tangible fixed assets | 22/27 | €429,225 | €450,064 | +€20,839 | +4.9% |
| Land and buildings | 22 | €428,347 | €449,806 | +€21,459 | +5.0% |
| Plant, machinery and equipment | 23 | €878 | €258 | -€620 | -70.6% |
| Current assets | 29/58 | €80,317 | €92,173 | +€11,857 | +14.8% |
| Current investments | 50/53 | €80,000 | €85,456 | +€5,456 | +6.8% |
| Cash at bank and in hand | 54/58 | €317 | €6,718 | +€6,401 | +2021.9% |
| Total equity and liabilities | 10/49 | €509,541 | €542,238 | +€32,696 | +6.4% |
| Equity | 10/15 | €463,896 | €468,729 | +€4,833 | +1.0% |
| Contributions | 10/11 | €37,200 | €37,200 | = | 0.0% |
| Reserves | 13 | €423,701 | €428,533 | +€4,832 | +1.1% |
| Non-distributable reserves | 130/1 | €3,720 | - | -€3,720 | |
| Reserves not available under the articles | 1311 | €3,720 | - | -€3,720 | |
| Distributable reserves | 133 | €419,981 | €428,533 | +€8,552 | +2.0% |
| Profit (loss) carried forward | 14 | €2,996 | €2,997 | +€1 | 0.0% |
| Amounts payable | 17/49 | €45,645 | €73,508 | +€27,863 | +61.0% |
| Amounts payable within one year | 42/48 | €45,645 | €73,508 | +€27,863 | +61.0% |
| Current portion of amounts payable after more than one year | 42 | €12,367 | - | -€12,367 | |
| Trade debts | 44 | €900 | €900 | = | 0.0% |
| Suppliers | 440/4 | €900 | €900 | = | 0.0% |
| Taxes, remuneration and social security | 45 | €198 | €2,681 | +€2,483 | +1253.8% |
| Taxes | 450/3 | €198 | €2,681 | +€2,483 | +1253.8% |
| Other amounts payable | 47/48 | €32,180 | €69,927 | +€37,747 | +117.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €24,695 | €24,465 | -€230 | -0.9% |
| Other operating charges | 640/8 | €1,583 | €1,630 | +€47 | +3.0% |
| Gross operating margin | 9900 | €27,816 | €28,267 | +€451 | +1.6% |
| Operating profit (loss) | 9901 | €1,538 | €2,172 | +€635 | +41.3% |
| Financial income | 75/76B | - | €5,456 | +€5,456 | |
| Recurring financial income | 75 | - | €5,456 | +€5,456 | |
| Financial charges | 65/66B | €359 | €118 | -€241 | -67.1% |
| Recurring financial charges | 65 | €359 | €118 | -€241 | -67.1% |
| Profit (loss) for the period before taxes | 9903 | €1,179 | €7,510 | +€6,331 | +537.2% |
| Income taxes | 67/77 | €198 | €2,677 | +€2,479 | +1251.4% |
| Profit (loss) for the period | 9904 | €981 | €4,833 | +€3,853 | +392.9% |
| Profit (loss) for the period to be appropriated | 9905 | €981 | €4,833 | +€3,853 | +392.9% |
Source: filed annual accounts (NBB), fiscal years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.